Global Neuromodulation Devices Report 2018-2028 - Visiongain Report

Tuesday, April 17, 2018 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

LONDON, April 17, 2018 /PRNewswire/ --

Deep Brain Stimulation (DBS),

Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

Report Details 

The neuromodulation devices market is estimated to

grow at a CAGR of 11.7% in the first half of the forecast period. The Spinal Cord Stimulation (SCS) submarket is estimated to account for 43.6% share of this market in 2018.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 221-page report you will receive 125 charts- all unavailable elsewhere.

The 221-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Neuromodulation Devices market forecasts from 2018-2028

• This report also breaks down the revenue forecast for the global neuromodulation devices market by type: • Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS) • Vagus Nerve Stimulation (VNS) • Sacral Nerve Stimulation (SNS) • Gastric Electrical Stimulation (GES) • Other Applications

This report discusses the market trends and lists the leading products/pipeline products of each submarket.

• This report provides individual revenue forecasts to 2028 for these regional and national markets: North America: the US and Canada Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific Latin America: Brazil, Mexico, Rest of Latin America • Rest of the World: Middle East, Africa

Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

• Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.

• Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry: • Medtronic • Boston Scientific • St Jude Medical (Abbott) • Cyberonics (LivaNova) • Stryker Corporation • Nevro Corp. • SetPoint Medical • Functional Neuromodulation • Neurotherapies Reset • Wringless Implantable Stretchable Electronics (WISE) • SceneRay • Mindray

Visiongain's study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.

Buy our report today Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.

To request a report overview of this report, please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on: https://www.visiongain.com/Report/2165/Global-Neuromodulation-Devices-Report-2018-2028

List of Companies Mentioned in the Report 

Abbott

Accellent

Advanced Uro-Solutions

Aleva Neurotherapeutics

Atrotech

Autonomic Technologies

Avery Biomedical

Axonics Modulation

Bard Electrophysiology

Bayer AG

BioControl Medical

Bioness, Inc.

BlueWind

Boston Scientific

CardioMEMS

Cerbomed GmbH

CerebralRx

CerebroMed

Cogentix Medical

Covidien

CVRx, Inc

Cyberonics

DBI

Deep Brain Innovations

electroCore

EndoNovo

EndoStim Inc

Enopace Biomedical

EnteroMedics

Functional Neuromodulation

Genesys Capital

Greatbatch

Halo Neuroscience

ImThera Medical

ImThera Medical, Inc.

InCube Labs

Integer Holdings Corporation

IoGyn, Inc.

Laborie Medical Technologies

Lake Region Medical

LivaNova

MagStim

MainStay Medical

Medtronic

Medtronic Eindhoven Design Centre (MEDC)

Medtronic International Trading Sarl

MedtronicNeuro

MetaCure

Metavention

Microtransponder

Mindray

Nanostim

NDI Medical

NeuImpulse

NeuroPace

NeuroSigma

NeuroStar

Neurotherapies Reset

NeuroTherm

NeuroVista Corp

NeuSpera

Nevro

Newronika

Nexstim plc

nUro Inc

Nuvectra Corporation

QiG Group,LLC

Rio Grande

Sapiens SBS

Sapiens Steering Brain Stimulation

SceneRay

Scion NeuroStim

SetPoint Medical

Sorin

SorinSpA

Soterix Medical

Spinal Modulation Inc

SPR Therapeutics

St. Jude Medical

StarMedTec

StimGuard, LLC.

Stimwave

Stryker Corporation

Synapse Medical

Urolplasty

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store